5th Annual IVI Methods Summit

In this keynote discussion, esteemed experts will discuss the intricate intersection of patient journey mapping and Health Technology Assessment (HTA) methodologies. This engaging session will underscore the significance of patient insights and collaborative approaches in shaping contemporary health research.

Building from IVI’s recent health equity reports, this session will highlight practical examples of how patients and researchers can partner to incorporate health equity into HTA and explore the research questions that need to come next.

Real Option Value calculates the benefit patients and caregivers receive from treatments that extend life, giving patients the chance to benefit from future treatment advances. Is this new method ready to be put into practice and what would it mean for people with life threatening conditions?

In 2023, IVI and EveryLife Foundation for Rare Disease collaborated on a PCORI-funded project on methods to identify common patient-centered outcomes across rare diseases. Learn what makes patient-centered HTA for rare disease different, and how these differences can inform HTA overall.

Dr. Jason Spangler, CEO of IVI, sits down with Dr. Eberechukwu Onukwugha, Professor in the Department of Practice, Sciences, and Health Outcomes Research at the University of Maryland School of Pharmacy in a fireside chat to discuss opportunities to make patient-centered HTA a reality.